Leif E. Pedersen serves as the President and Chief Commercial Officer at Certara, Inc., a leading provider of biosimulation software and technology-enabled services. With a robust background in the life sciences industry, Pedersen has been instrumental in steering Certara's commercial strategy and growth. He joined Certara in 2017 and has since played a pivotal role in expanding the company's global presence and enhancing its service offerings to pharmaceutical and biotechnology clients. Before joining Certara, Pedersen held various leadership positions in the industry, including roles at MedImmune, a subsidiary of AstraZeneca, where he was Senior Vice President and Head of Global Commercial Operations. His tenure at MedImmune saw significant advancements in the commercialization of biologics and vaccines, showcasing his ability to drive business growth and operational excellence. Pedersen's strategic vision and deep understanding of the life sciences sector have been key factors in his success at Certara, where he oversees the company's commercial operations, including sales, marketing, and customer engagement. Under Pedersen's leadership, Certara has achieved notable milestones, such as the successful acquisition and integration of several strategic companies, which have bolstered its capabilities in drug development and regulatory science. His focus on innovation and customer-centric solutions has helped Certara maintain its position as a trusted partner in the pharmaceutical industry. Pedersen's contributions have not only driven Certara's commercial success but also reinforced its commitment to advancing healthcare through cutting-edge technology and scientific expertise.